Task: Please answer the following question about the molecule with SMILES N#Cc1ccc2c(c1)[C@H]1CCCN(C(=O)c3ccc4[nH]cnc4c3)[C@H]1C2.
Request: Is it known if this drug is the first approved in its class, regardless of the indication or route of administration, acting on a specific target?
Answer: No
Task: Please answer the following question about the molecule with {SMILES__description} {SMILES#}.
{#Description|Question|Request!}: {quest#}
{#Result|Answer|Completion!}: {answ#}
N#Cc1ccc2c(c1)[C@H]1CCCN(C(=O)c3ccc4[nH]cnc4c3)[C@H]1C2
N#Cc1ccc2c(c1)[C@H]1CCCN(C(=O)c3ccc4[nH]cnc4c3)[C@H]1C2
(4aR,9aS)-1-(1H-benzimidazol-5-ylcarbonyl)-2,3,4,4a,9,9a-hexahydroindeno[2,1-b]pyridine-6-carbonitrile
Is it known if this drug is the first approved in its class, regardless of the indication or route of administration, acting on a specific target?